Prostate cancer imaging developed by university researchers has shown “extremely encouraging” results in its first clinical trials. A team at Heriot-Watt University, Edinburgh, leading the clinical ...

Clarity Pharmaceuticals (ASX:CU6) has seen the U.S. FDA fast-track its prostate cancer imaging compound for use in PET scans on patients with recurring prostate cancer. The stock jumped 4% in the ...

It has good sensitivity rate for prostate cancer detection. Diffusion-weighted imaging improves the accuracy of cancer detection when added to conventional MRI. It is useful for identifying ...

Dr. Christopher Flowers discusses MRD testing in cancer care, why this is an important concept to understand and how it ...

The increasing usage of an imaging drug, Cytalux, enables surgeons to identify and then remove more, if not all cancer cells ...

Bladder cancer is one of the most common malignant tumors in urinary system, and the treatment faces huge challenges.

The study, published in JAMA Network Open, found that nearly half of high-risk prostate cancer patients previously classified as nonmetastatic by conventional imaging actually have metastatic disease ...

Adding serial circulating tumor DNA (ctDNA) assays to standard of care imaging surveillance had limited clinical benefits in ...

Prostate cancer imaging developed by university researchers has shown “extremely encouraging” results in its first clinical trials. A team at Heriot-Watt University, Edinburgh, leading the ...